Work

Risk of systemic lupus erythematosus flare after COVID-19 hospitalization: A matched cohort study

Year: 2024

Type: article

Abstract: OBJECTIVE: To analyze the risk of systemic lupus erythematosus (SLE) flare after admission for COVID-19. METHODS: We performed a matched cohort study using the Assistance Publique-Hôpitaux de Paris Clinical Data Warehouse which collects structured medical, biological and administrative information from 11 million patients in Paris area, France. Each SLE patient hospitalized with a COVID-19 diagnosis code between March 2020 and December 2021 was matched to one SLE control patient with an exact matching procedure using age ±3 years, gender, chronic kidney disease, end-stage renal disease, and serological activity. The main outcome was a lupus flare during the 6 months follow-up. A flare was considered if a) documented by the treating physician in the patient's EHR and b) justifying a change in SLE treatment. The electronic health records (EHRs) were individually checked for data accuracy. RESULTS: Among 4,533 SLE patients retrieved from the database, 81 (2.8%) have been admitted for COVID-19 between March 2020 and December 31, 2021, and 79 (n = 79/81,97.5%) were matched to a unique unexposed SLE. During follow-up, a flare occurred in 14 (17.7%) patients from the COVID-19 group as compared to 5 (6.3%) in the unexposed control group, including 4 lupus nephritis in the exposed group and 1 in the control group. After adjusting for HCQ use at index date and history of lupus nephritis, the risk of flare was higher in exposed SLE patients (hazard ratio [95% confidence interval] of 3.79 [1.49-9.65]). CONCLUSIONS: COVID-19 hospitalization is associated with an increased risk of flare in SLE.

Source: PLoS ONE

DOI: 10.1371/journal.pone.0309316

Authors: Arthur Mageau, Christel Géradin, Kankoé Sallah, Thomas Papo, Karim Sacre, Jean-François Timsit